The prevalence of chronic kidney disease in a Flemish primary care morbidity register

Jan Degryse

首页> 外文期刊>Age and Ageing >The prevalence of chronic kidney disease in a Flemish primary care morbidity register

【24h】

The prevalence of chronic kidney disease in a Flemish primary care morbidity register

机译：弗拉芒地区初级保健发病率登记册中慢性肾脏病的患病率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Age and Ageing》 |2012年第2期|p.231-233|共3页
作者
Jan Degryse;
展开▼
作者单位

Katholieke Universiteit Leuven, @%@, Maastricht University, @%@, Université Catholique de Louvain, @%@To whom correspondence should be addressed Tel: (+32) 16 33 27 30;

Fax: (+32) 16 33 74 80. Email:;

展开▼
收录信息美国《科学引文索引》(SCI);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The prevalence of chronic kidney disease in a Flemish primary care morbidity register [J] . Age and Ageing: The Journal of the British Geriatrics Society and the British Society for Research on Ageing . 2012,第2期

机译：弗拉芒地区初级保健发病率登记册中慢性肾脏病的患病率
2. Prevalence of chronic diseases and morbidity in primary health care in central Greece: An epidemiological study [J] . Markos Minas, Nikolaos Koukosias, Elias Zintzaras, BMC Health Services Research . 2010,第1期

机译：希腊中部地区初级卫生保健中慢性病和发病率的流行病学研究
3. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25?mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial [J] . Nathan R Hill, Daniel Lasserson, Ben Thompson, Trials . 2014,第1期

机译：醛固酮受体拮抗作用在慢性肾脏病（BARACK D）试验中的益处-一项多中心，前瞻性，随机，开放，盲点终点研究，为期3个月，研究对象为2,616名3b期慢性肾脏病初级保健患者，以比较螺内酯25毫克/天的常规治疗对死亡率和心血管疾病的疗效，与常规治疗相比，每天一次：随机对照试验的研究方案
4. Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease across stages of disease [C] . Brecht Van Berkel, Chantal van Ongeval, Amaryllis van Craenenbroeck, International Workshop on Breast Imaging . 2020

机译：慢性肾脏病患者跨疾病阶段的乳腺动脉钙化的患病率，进展及其影响
5. Systematic analysis of national, regional, and global trends in chronic kidney disease mortality, morbidity, and etiology. [D] . Wulf, Sarah. 2012

机译：对慢性肾脏病死亡率，发病率和病因学的国家，地区和全球趋势进行系统分析。
6. Prevalence of chronic diseases and morbidity in primary health care in central Greece: An epidemiological study [O] . Markos Minas, Nikolaos Koukosias, Elias Zintzaras, 2010

机译：希腊中部初级卫生保健中慢性病和发病率的流行病学研究
7. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial [O] . Hill, NR, Lasserson, D, Thompson, B, 2014

机译：醛固酮受体拮抗作用在慢性肾脏病（BARACK D）试验中的益处–一项多中心，前瞻性，随机，开放，盲点终点研究，为期3个月，研究对象为2,616名3b期慢性肾脏病初级保健患者，以比较螺内酯25 mg除常规治疗对死亡率和心血管结局的每日疗效与单独常规治疗相比，每天一次：随机对照试验的研究方案

The prevalence of chronic kidney disease in a Flemish primary care morbidity register

著录项

相似文献

相关主题

期刊订阅